AtmanCo Inc.
TSX VENTURE : ATW

AtmanCo Inc.

May 30, 2013 08:00 ET

AtmanCo Files Its Consolidated Financial Results for the First Quarter of 2013 and Presents a Summary of Its Activities

MONTREAL, QUEBEC--(Marketwired - May 30, 2013) - AtmanCo Inc. ("AtmanCo" or the "Company") (TSX VENTURE:ATW) has filed its consolidated interim financial statements for the quarter ended March 31, 2013.

Highlights of the First Quarter of 2013

  • Increase in consolidated sales by the Company of almost 300%, rising from $118,675 to $353,879, due in part to the reverse takeover.
  • Increase in sales in the human resources sector of $97,660, approximately 82% higher than the previous comparable period, as well as an increase in the gross margin from 73% to 90%.
  • Deferred revenues of $284,628 on May 31, 2013.
  • Translation of the Atman Test into three additional languages (complementing the languages currently available, i.e. English, French and Spanish) to enable the development of new markets (Portuguese, German and Dutch).

Activity Summary

During the first quarter of 2013, sales by the Company improved $235,222 over the quarter ended February 29, 2012. This increase is due to the reverse takeover as well as a sales augmentation in the human resources sector. AtmanCo increased its efforts with potential partners and customers to develop new markets, notably in Europe. In addition, the Atman Test was revised and translated into three additional languages, enabling the Company to reach the Portuguese, German and Dutch markets.

These international efforts ran concurrent to development initiatives closer to home, with AtmanCo announcing it had entered into a partnership with Canadian telecommunications leader Videotron for the use of the platform of psychometric tests developed by AtmanCo and the creation of corporate standards.

(in thousands of $) January 1, 2013
to
March 31, 2013
December 1, 2011
to
February 29, 2012
Human
Resources

Cyberhealth

Total
Human
Resources

Cyberhealth

Total
Products 216 138 354 119 119
Cost of goods sold
Depreciation 22 43 65 33 33
Other 75 75
Gross margin 194 20 214 86 86
90 % 14 % 60 % 73 % 73 %
(in thousands of $) March 31, 2013 December 31, 2012
Deferred revenues 186 99 285 161 13 174

Excluding depreciation, the Company saw its gross margin increase by $170,000 over the comparable quarter.

The results for the quarter ended February 29, 2012 do not include the results associated with the Company's cyberhealth activities since the reverse takeover took place on October 18, 2012. Since quarters do not end on the same day, the Company used the fiscal period ended February 29, 2012 for analysis purposes as comparable quarter, given that these data are the most reflective of the current period.

Changes to the Board of Directors

In January 2013, the Company appointed Susan Kudzman as a board member of AtmanCo. In April 2013, Catherine Loubier left her position as a member of the AtmanCo Board of Directors.

The above data comprise a summary of highlights. For further information, please consult the Company's consolidated financial statements as well as the Management Report for the fiscal quarter ended March 31, 2013, at www.sedar.com.

About AtmanCo

Field of human ressources

AtmanCo helps executives and managers recruit qualified human resources and place the right person in the right position. AtmanCo created the Atman personality test - a simple, accurate and scientifically proven psychometric test with four modules: At•Plus, At•Model, At•Matchand At•Team. Each test and its modules identify factors that shape an individual's personality and influence their performance. User-friendly and easy to use, these proven tools for developing human potential integrate easily into the recruitment, organizational evaluation, and talent management processes.

Field of cyberhealth

The Company's mission is to provide corporations as well as health and physical conditioning professionals with the means to enhance the value and efficiency of their customer services, to offer personalized corrective solutions for posture and physical condition, including exercise programs and eventually innovative orthoses destined to improve the well-being of people suffering from backaches or other musculoskeletal disorders and to improve people's physical and mental condition as well as their general health, by harnessing leading edge technologies in the fields of posture and biomechanics.

The Company stands out in its marketing approach via its Web site, direct sales and partner network. For further information, visit www.atmanco.com and www.biotonix.com sites.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While AtmcanCo anticipates that subsequent events and developments may cause its views to change, AtmcanCo specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.

The TSX Venture Exchange and its Regulatory Services provider (as per meaning assigned to this term in TSX Venture Exchange's policies) bear no liability as to the relevance or accuracy of this press release.

Contact Information

  • SOURCE:
    AtmanCo Inc.
    Michel Guay
    President and CEO
    514.935.5959 ext. 301
    www.atmanco.com